Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

talc

J&J fined $72 million in talc cancer case

February 24, 2016 Research and Development, Sales and Marketing Johnson & Johnson

A Missouri jury has ruled that Johnson & Johnson must pay $72 million to the family of an Alabama woman, …
News
howard_schiller_valeant

Valeant likely to restate financial results after Philidore review

February 23, 2016 Manufacturing and Production, Medical Communications, Sales and Marketing Howard Schiller, Philidore, Valeant

Valeant says it is likely to restate its financial results for the last two years, in the wake of the …
News

Europe approves Bayer haemophilia drug

February 22, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, haemophilia a

Bayer has received approval from the European Commission for its haemophilia A drug Kovaltry (octocog alfa) in patients of all …
News
pharmafocus_march_front_cover

March edition of Pharmafocus live

February 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The March 2016 edition of Pharmafocus is now live and available to read here.
News
amgen_ucb

Amgen and UCB announce positive romosozumab results

February 22, 2016 Medical Communications, Research and Development, Sales and Marketing Amgen, Romosozumab, UCB, osteoporosis

Romosozumab development partners Amgen and UCB have announced positive top-line results from a Phase III study of the drug in postmenopausal …
News
sarah_opendi_and_rasha_kelej_at_the_campaigns_launch

Merck launches infertility programme in Uganda

February 22, 2016 Medical Communications, Sales and Marketing Merck Serono

Germany’s Merck has extended its infertility programme ‘Merck More than a Mother’ to Uganda, launching the campaign in a second …
News
sanofi

FDA to decide on Sanofi diabetes combo

February 22, 2016 Research and Development, Sales and Marketing Lantus, Sanofi

Sanofi will be looking to August for a decision on its new type 2 diabetes combo LixiLan (lixisenatide and Lantus), …
News

Pfizer pays $784m to settle Protonix overcharge claims

February 17, 2016 Research and Development, Sales and Marketing Medicaid, Pfizer, Wyeth, protonix

US drugs giant Pfizer is to pay more than $784 million to settle claims that it overcharged health insurer Medicaid …
News
brexit

What would BREXIT mean for pharma?

February 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing research and development

It began with a promise to UK voters to end ‘benefit tourism’ and to negotiate more flexibility in the UK’s …
Feature
eli_lilly

Lilly suffers damaging Alimta patent blow

February 15, 2016 Manufacturing and Production, Sales and Marketing Actavis, Alimta, Allergan, Eli Lilly, pemetrexed

Eli Lilly says it plans to appeal a UK High Court’s verdict that could imminently open its blockbuster lung cancer …
News
cancer_cells_blue

New 10-minute test will diagnose cancer at home

February 15, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Cancer

Scientists have developed a test for cancer that can diagnose the disease at home with the aid of just a …
News
hilary_clinton_speaks_at_a_rally_in_des_moines_in_january

FEC stats reveal pharma donations to presidential runners

February 12, 2016 Sales and Marketing

Stats from the Center for Responsive Politics and the Federal Election Commission (FEC), have revealed the extent of donations from the …
News
opdivo

UK patients get early access to Opdivo for kidney cancer

February 12, 2016 Medical Communications, Sales and Marketing

Bristol Myers-Squibb’s Opdivo (nivolumab) will be available through the Early Access to Medicines  Scheme (EAMS) as a monotherapy to UK …
News
amgen_flag

Amgen’s Kyprolis now available to UK multiple myeloma patients

February 12, 2016 Medical Communications, Sales and Marketing Amgen, Kyprolis, multiple myeloma

Amgen has announced the UK launch of Kyprolis (carfilzomib) in combination with Revlimid (lenalidomide) and dexamethasone for the treatment of …
News
fda

Biosimilars: Can the US catch up in 2016?

February 12, 2016 Medical Communications, Sales and Marketing Eli Lilly, Enbrel, FDA, Neulasta, Novartis, Pfizer, Sandoz, Zarxio, biosimilars

What are biosimilars? Biosimilars are essentially the biological equivalent of generic drugs to their branded small-molecule counterparts (what Ibuprofen is …
Feature
The Gateway to Local Adoption Series

Latest content

Trio become latest Symbiosis commercial additions

October 12, 2026

UK immunoglobulin supply faces growing pressure, report warns

October 12, 2026

How will biomarker-led diagnostics reshape respiratory medicine?

October 11, 2026

Five Facts about COPD

October 11, 2026

“That gap between innovation and delivery was what stood out to me most”

October 11, 2026